Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

19/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Conformis, Inc. (CFMS) generated $-11.29M in operating cash flow for quarter ending 2023-06-30. After capital expenditures of $308K, free cash flow was $-11.6M.

Free cash flow margin was -89.1% of revenue. Cash conversion ratio was 0.87x, suggesting some earnings are non-cash.

Criteria supported by this page:

HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
MOAT (21/100, Fail) — limited free cash flow weakens the competitive position
INCOME (10/100) — Cash conversion ratio was 0.87x suggests some earnings are non-cash items

Overall SharesGrow Score: 19/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

19/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✗

FUTURE

20/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

21/100

Proven by this page

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Conformis, Inc. Cash Flow History

Metric	TTM	Q2 FY2023	Q1 FY2023	Q4 FY2022	Q3 FY2022
Operating Cash Flow	$-44.53M	$-11.29M	$-9.85M	$-11.36M	$-12.03M
Capital Expenditure	$-2.14M	$-308K	$-907K	$-321K	$-607K
Free Cash Flow	$-46.67M	$-11.6M	$-10.75M	$-11.68M	$-12.64M